These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 30827260)
21. Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? Ahmed H; Salem A; Atta H; Ghazy M; Aglan H Hum Exp Toxicol; 2014 Dec; 33(12):1217-31. PubMed ID: 24567299 [TBL] [Abstract][Full Text] [Related]
22. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model. Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934 [TBL] [Abstract][Full Text] [Related]
23. Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease. Chung TH; Hsu SC; Wu SH; Hsiao JK; Lin CP; Yao M; Huang DM Nanoscale; 2018 Feb; 10(6):2998-3007. PubMed ID: 29372743 [TBL] [Abstract][Full Text] [Related]
24. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro. Jin GZ; Cho SJ; Choi EG; Lee YS; Yu XF; Choi KS; Yee ST; Jeon JT; Kim MO; Kong IK Cell Biol Int; 2008 Nov; 32(11):1433-8. PubMed ID: 18778785 [TBL] [Abstract][Full Text] [Related]
25. Conditioned medium from human amniotic epithelial cells may induce the differentiation of human umbilical cord blood mesenchymal stem cells into dopaminergic neuron-like cells. Yang S; Sun HM; Yan JH; Xue H; Wu B; Dong F; Li WS; Ji FQ; Zhou DS J Neurosci Res; 2013 Jul; 91(7):978-86. PubMed ID: 23633297 [TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons. Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268 [TBL] [Abstract][Full Text] [Related]
27. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Koh SH; Kim KS; Choi MR; Jung KH; Park KS; Chai YG; Roh W; Hwang SJ; Ko HJ; Huh YM; Kim HT; Kim SH Brain Res; 2008 Sep; 1229():233-48. PubMed ID: 18634757 [TBL] [Abstract][Full Text] [Related]
28. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease. Venkatesh K; Sen D Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480 [TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells and neuroregeneration in Parkinson's disease. Glavaski-Joksimovic A; Bohn MC Exp Neurol; 2013 Sep; 247():25-38. PubMed ID: 23542820 [TBL] [Abstract][Full Text] [Related]
31. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases. Lescaudron L; Naveilhan P; Neveu I Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567 [TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552 [TBL] [Abstract][Full Text] [Related]
33. Human placental stem cells: biomedical potential and clinical relevance. Malek A; Bersinger NA J Stem Cells; 2011; 6(2):75-92. PubMed ID: 22997848 [TBL] [Abstract][Full Text] [Related]
34. Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis. Manzini BM; da Silva Santos Duarte A; Sankaramanivel S; Ramos AL; Latuf-Filho P; Escanhoela C; Kharmandayan P; Olalla Saad ST; Boin I; Malheiros Luzo ÂC Cytotherapy; 2015 Aug; 17(8):1052-65. PubMed ID: 26139545 [TBL] [Abstract][Full Text] [Related]
35. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. L PK; Kandoi S; Misra R; S V; K R; Verma RS Cytokine Growth Factor Rev; 2019 Apr; 46():1-9. PubMed ID: 30954374 [TBL] [Abstract][Full Text] [Related]
36. Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease. Li M; Zhang SZ; Guo YW; Cai YQ; Yan ZJ; Zou Z; Jiang XD; Ke YQ; He XY; Jin ZL; Lu GH; Su DQ Neurochem Res; 2010 Oct; 35(10):1522-9. PubMed ID: 20658188 [TBL] [Abstract][Full Text] [Related]
37. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863 [TBL] [Abstract][Full Text] [Related]
38. An injectable conductive Gelatin-PANI hydrogel system serves as a promising carrier to deliver BMSCs for Parkinson's disease treatment. Xue J; Liu Y; Darabi MA; Tu G; Huang L; Ying L; Xiao B; Wu Y; Xing M; Zhang L; Zhang L Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():584-597. PubMed ID: 30948095 [TBL] [Abstract][Full Text] [Related]
39. Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease. Schwerk A; Altschüler J; Roch M; Gossen M; Winter C; Berg J; Kurtz A; Akyüz L; Steiner B Regen Med; 2015 May; 10(4):431-46. PubMed ID: 26022763 [TBL] [Abstract][Full Text] [Related]
40. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy. Bier A; Berenstein P; Kronfeld N; Morgoulis D; Ziv-Av A; Goldstein H; Kazimirsky G; Cazacu S; Meir R; Popovtzer R; Dori A; Brodie C Biomaterials; 2018 Aug; 174():67-78. PubMed ID: 29783118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]